Circulating microRNA-30a-5p, microRNA-101-3p, microRNA-140-3p and microRNA-141-3p as potential biomarkers for dexmedetomidine response in pediatric patients-Reference-Cited by-同舟云学术

Circulating microRNA-30a-5p, microRNA-101-3p, microRNA-140-3p and microRNA-141-3p as potential biomarkers for dexmedetomidine response in pediatric patients

Published:2021-07-03 Issue:12 Volume:77 Page:1853-1859
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Cai Xinmei^ORCID,Li Bilian,Wei Wei,Guan Yanping,Bai Xue,Huang Min,Huang Yaying,Rong Lili,Song Xingrong,Zhong Guoping

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00228-021-03178-x.pdf

Reference34 articles.

1. Mohite V, Baliga S, Thosar N et al (2019) Role of dexmedetomidine in pediatric dental sedation. J Dent Anesth Pain Med 19:83–90. https://doi.org/10.17245/jdapm.2019.19.2.83

2. Paris A, Tonner PH (2005) Dexmedetomidine in anaesthesia. Curr Opin Anaesthesiol 18:412–418. https://doi.org/10.1097/01.aco.0000174958.05383.d5

3. Cozzi G, Norbedo S, Barbi E (2017) Intranasal dexmedetomidine for procedural sedation in children, a suitable alternative to chloral hydrate. Paediatr Drugs 19:107–111. https://doi.org/10.1007/s40272-017-0217-5

4. Jakob SM, Ruokonen E, Grounds RM et al (2012) Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA 307:1151–1160. https://doi.org/10.1001/jama.2012.304

5. Yuen VM, Hui TW, Irwin MG et al (2010) Optimal timing for the administration of intranasal dexmedetomidine for premedication in children. Anaesthesia 65:922–929. https://doi.org/10.1111/j.1365-2044.2010.06453.x

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insight into Cardioprotective Effects and Mechanisms of Dexmedetomidine;Cardiovascular Drugs and Therapy;2024-06-13

2. Dexmedetomidine attenuates lipopolysaccharide-induced inflammation through macrophageal IL-10 expression following α7 nAchR activation;International Immunopharmacology;2022-08

3. The Role of miRNAs in Dexmedetomidine’s Neuroprotective Effects against Brain Disorders;International Journal of Molecular Sciences;2022-05-13